Amarin Corporation plc News
Cramer's Mad Money Recap: Southwest, Disney, FedEx
Jim Cramer says that as fears over the economy and Evergrande have eased, the only thing left to fear right now is COVID.
'Mad Money' Lightning Round: Xilinx, Keysight Technologies
Jim Cramer’s bullish on Xilinx and Keysight Technologies, but says Amarin is only for speculation.
Vaccine vs. Virus: Cramer's 'Mad Money' Recap (Monday 12/14/20)
Jim Cramer says the pandemic will end, but not immediately. He's looking at stocks and sectors poised to move as lockdowns increase.
Amarin Jumps on Heart-Drug Progress in China Trial
Amarin's cardiovascular-disease treatment Vascepa met its key endpoint in a late-stage trial in China.
Amarin Loses Appeal in Heart Treatment Patent Case
The U.S. Court of Appeals makes its ruling one day after hearing arguments in the case.
Amarin Shares Off - Analysts Mull Prospects of Patent-Case Appeal
Amarin shares are lower after analysts assessed how the judges in the company's patent-case appeal might rule.
Tale of Two Recoveries: Cramer's 'Mad Money' Recap (Tuesday 8/18/20)
Jim Cramer says the stock market may be making new highs, but that doesn't mean we're in a V-shaped economic recovery.
Twilight for Index Funds: Cramer's 'Mad Money' Recap (Wednesday 4/15/20)
Jim Cramer says that trying to mirror the market can be a bad strategy in times like this.
Cisco Systems Stock Leaps On Q4 Earnings Beat, 2023 Sales Outlook As Supply Chain Pressures Ease
"Overall supply constraints began to ease slightly at the back half of the fourth quarter and continuing into the start of the first quarter," said CEO Chuck Robbins.
Ransomware Suspect Charged in U.S. as Incidents Surge
A Russian citizen is charged in the U.S. for his alleged role in an international cryptocurrency money laundering conspiracy.
TheStreet's Doug Kass: Don't Be Fooled by Stock Rally
The S&P 500 index has jumped 11% in the past month, 'reducing the general attraction of equities,' investor Doug Kass says.